Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6 instead of Revision: v3.6.5, indicating a software update. The study content and layout remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-31T16:54:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a new build or patch of the site or documentation rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T11:50:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.3 to v3.6.4. This appears to be a minor software update with no evident changes to content or user-facing features in the provided context.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's update dates were refreshed in July 2026, replacing earlier January 2026 timestamps. This reflects routine maintenance to keep the study record's metadata current.
    Difference
    0.2%
    Check dated 2026-07-20T02:13:24.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new build of the page content without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-07-05T14:34:38.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new publication citation by Derbala et al. was added to the study's Publications, documenting AI-guided analysis predicting pembrolizumab response in rare tumors. The page revision was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-28T08:47:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.